EPOgen and Restrictive Transfusions in Patients Undergoing Cardiac Surgery (EPORT)

NCT02802592 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Loss of funding

Conditions

Cardiac Surgery-CABG
Cardiac Valve Replacement

Interventions

DRUG: Epogen
DRUG: Normal Saline

Sponsor

Johns Hopkins University